A total of 41 specimens were submitted to the Molecular and & Genomic Pathology Laboratory at University of Pittsburgh Medical Center for targeted next-generation sequencing. From formalin-fixed ...

Biliary tract carcinoma, including carcinoma of the gallbladder, intrahepatic bile ducts (cholangiocarcinoma), and extrahepatic bile ducts, affects 7500 people in the United States annually, and has ...

SAN DIEGO, California — A survey of Western patients with intestinal metaplasia of the stomach (IMS) shows they are at an 11-fold risk for gastric carcinoma (GCA) and that the median time to ...

A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. Background: p16INK4a is a cyclin-dependent kinase inhibitor, together with p21, p53 ...

Quality indicator for esophagogastroduodenoscopy in screening gastric cancer. A prospective study of repeat endoscopic biopsy to identify HER2-positive tumors following an initial HER2-negative biopsy ...

HONOLULU — In a retrospective analysis, researchers found gastric intestinal metaplasia to be more prevalent among the U.S. population than previously thought, according to an oral presentation at ACG ...

Medically reviewed by Qin Rao, MD Intestinal metaplasia is a condition involving cell changes in the upper digestive tract lining.Helicobacter pylori infection is the greatest risk factor for ...

A new study reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's esophagus and high-grade dysplasia or early mucosal cancer have a ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Biopsies using a wide-area transepithelial sampling brush helped diagnose intestinal metaplasia in ...

Barrett’s oesophagus (BE) is a condition in which the mucosa, due to chronic irritation with gastric or gastro-duodenal content, undergoes adaptive rear-rangement with columnar cells’ proliferation ...

Radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer, according to a landmark clinical trial ...